Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-25T18:30:07.535Z Has data issue: false hasContentIssue false

Template-Mediated Biomineralization of Hemozoin

Published online by Cambridge University Press:  10 February 2011

David W. Wright
Affiliation:
Duquesne University, Dept. of Chemistry and Biochemistry, Pittsburgh, Pennsylvania 15282–1530
James Ziegler
Affiliation:
Duquesne University, Dept. of Chemistry and Biochemistry, Pittsburgh, Pennsylvania 15282–1530
Get access

Abstract

A critical target for the development of new antimalarial treatments is the detoxification pathway of free heme released during the catabolism of host hemoglobin in the digestive vacuole of the malaria parasite Plasmodium falciparum. We have synthesized and examined two peptide dendrimers (BNT I and II) based on the tandem repeat motif of HRP II from P. falciparum for their abilities to both bind heme substrates and to form the critical detoxification polymer hemozoin. Each substrate was capable of binding significant amounts of the natural substrate Fe(III)PPIX along with other substrates such as Zn(II)PPIX and the metal free PPIX. Further, it was shown that the dendrimeric BNT I and II were capable of supporting the aggregation of hemozoin and that this process could be inhibited by the known antimalarial drug, chloroquine.

Type
Research Article
Copyright
Copyright © Materials Research Society 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. During the intraerythrocytic phase of its life cycle, the malaria parasite can degrade up to 80% of an infected erythrocyte's hemoglobin to obtain requisite amino acids for its maturation. Olliaro, P. J., Goldberg, D. E., Parasitol. Today. 11, p. 294 (1995);Google Scholar
Rosenthal, P. J., McKerrow, J. H., Aikawa, M., Nagasawa, H., Leech, J. H. Clin, J.. Invest. 82, p. 1560 (1988);Google Scholar
Goldberg, D. E., Slater, A. F. G., Cerami, A., Henderson, G. B., Proc. Natl. Acad. Sci. U. S. A. 87, p. 2931 (1990).Google Scholar
2. Slater, A. F. G., Exp. Parisitology. 74, p. 362 (1992); G. A. Jamjoom, Rev. Infect. Dis. 10, p. 1029 (1988).Google Scholar
3. Pagola, S., Stephens, P. W., Bohle, D. S., Madsen, S. K., Nature in press.Google Scholar
4. Sullivan, D. J. Jr., Gluzman, I. Y., Goldberg, D. E., Science 272, p. 219 (1996).Google Scholar
5. Maim, S. J., J. Chem. Soc., Dalton Trans. p. 1 (1993); Mann, S., Nature 365, p. 499 (1993).Google Scholar
6. Bodansky, M., Bodansky, A., The Practice of Peptide Synthesis, 2nd ed. Springer-Verlag, Amsterdam (1994).Google Scholar
7. Use of allyl-based protecting groups for the automated synthesis of multiple antigenic (MAP) peptides on the 9050 plus PepSynthesizer. Peptide Synthesis: application note, Millipore p. 1 (1996).Google Scholar
8. Morgan, W. T., Biochem. 24, p. 1496 (1985); M. K. Burch, W. T. Morgan, Biochem. 24, p. 5919 (1985).Google Scholar
9. Hahn, K. W., Klis, W. A., Stewart, J. M., Science 248, p. 1544 (1990).Google Scholar
10. HRP II (Mr 35 kD) contains 51 repeats of the sequence Ala-His-His (76%of the mature protein is histidine and alanine). HRP III (Mr 27 kD) contains 28 Ala-His-His sequences (56% of the mature protein is histidine and alanine). Wellems, T. E., Howard, R. J.,Proc. Natl. Acad. Sci. U. S. A. 83, p. 6065 (1986).Google Scholar
11. Shelnutt, J. A., Inorg. Chem. 22, p. 2535 (1983); J. A. Shelnutt, M. M. Dobry, J. D. Satterlee, J. Phys. Chem. 88, p. 4980 (1984); J. A. Shelnutt J. Phys. Chem. 88, p. 4988 (1984).Google Scholar
12. Martiney, J. A., Cerami, A., Salter, A. F. G., Mol. Med. (Tokyo) 2, p. 236 (1996).Google Scholar